National Research (NRCIA) Downgraded by BidaskClub

National Research (NASDAQ:NRCIA) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Friday.

Separately, Zacks Investment Research downgraded shares of National Research from a “hold” rating to a “strong sell” rating in a report on Friday, November 10th.

Shares of National Research (NRCIA) traded up $0.85 during mid-day trading on Friday, hitting $37.35. 28,209 shares of the company traded hands, compared to its average volume of 23,294. The company has a market cap of $914.40, a P/E ratio of 52.61 and a beta of 1.63. National Research has a 1-year low of $16.50 and a 1-year high of $41.99.

National Research (NASDAQ:NRCIA) last announced its earnings results on Tuesday, November 7th. The business services provider reported $0.09 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.12). National Research had a return on equity of 30.84% and a net margin of 19.09%. equities research analysts forecast that National Research will post 0.88 EPS for the current year.

In other National Research news, major shareholder K/I/E/Trust Under Agreement 3/ sold 2,127 shares of National Research stock in a transaction dated Wednesday, October 25th. The shares were sold at an average price of $38.00, for a total value of $80,826.00. Following the completion of the sale, the insider now owns 5,655,489 shares in the company, valued at approximately $214,908,582. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 25,715 shares of company stock valued at $963,670 in the last ninety days. 37.54% of the stock is currently owned by insiders.

Institutional investors have recently modified their holdings of the business. Schwab Charles Investment Management Inc. raised its position in shares of National Research by 13.3% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 42,164 shares of the business services provider’s stock valued at $1,573,000 after buying an additional 4,952 shares in the last quarter. California Public Employees Retirement System raised its position in shares of National Research by 38.8% in the 3rd quarter. California Public Employees Retirement System now owns 41,929 shares of the business services provider’s stock valued at $1,581,000 after buying an additional 11,729 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of National Research by 1.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 605,856 shares of the business services provider’s stock valued at $22,841,000 after buying an additional 7,666 shares in the last quarter. Hillsdale Investment Management Inc. raised its position in shares of National Research by 22.1% in the 3rd quarter. Hillsdale Investment Management Inc. now owns 33,100 shares of the business services provider’s stock valued at $1,248,000 after buying an additional 6,000 shares in the last quarter. Finally, Wells Fargo & Company MN raised its position in shares of National Research by 75.2% in the 3rd quarter. Wells Fargo & Company MN now owns 9,450 shares of the business services provider’s stock valued at $356,000 after buying an additional 4,056 shares in the last quarter. Institutional investors and hedge funds own 24.90% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “National Research (NRCIA) Downgraded by BidaskClub” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.americanbankingnews.com/2018/01/21/national-research-nrcia-downgraded-by-bidaskclub.html.

National Research Company Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply